What If I Don't Qualify for Transplant? for AML Patients
Event Description
Bone marrow transplant (BMT) is currently the only curative treatment for AML patients. But what if you don't qualify for transplant? Dr. Brittany Ragon joins us to talk about what options AML patients have when transplant is not an option.
Schedule & Agenda
Mary introduces the agenda for the event and featured speaker Dr. Brittany Ragon
Mary introduces the agenda for the event and featured speaker Dr. Brittany Ragon
Dr. Brittany Ragon talks about what options AML patients have when transplant is not available
Dr. Brittany Ragon talks about what options AML patients have when transplant is not available
Type your questions in the chat and we will answer them!
Type your questions in the chat and we will answer them!
Speakers & Moderators
Mary joined HealthTree in 2022. She is now the AML & MDS Community and Education Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.
Dr. Brittany Knick Ragon is an Associate Professor in the Department of Internal Medicine at Wake Forest University School of Medicine and Director of Hematology Operations at Levine Cancer Institute in Charlotte, North Carolina. She joined the Leukemia Division at Atrium Health Levine Cancer in 2017 as an adult leukemia and transplant specialist. Her clinical expertise is in acute leukemias, myeloid diseases, allogeneic transplant, hereditary hematologic predisposition syndromes, and bone marrow failure syndromes. Her research is focused on utilizing protein and gene exploration to identify biologically informed therapeutic targets for myeloid malignancies. Through increased understanding of the molecular and genetic landscape of myelodysplastic syndromes and acute leukemias, she aims to find markers for response prediction, toxicity limitation, and to optimize currently available and novel therapeutics. She also has a complementary research focus in efforts to mitigate healthcare disparities in acute leukemia patients. In addition to her translational work, she serves as principal investigator on several clinical trials in acute leukemias. For her research efforts, she has received grant funding from the Leukemia Research Foundation, Shannon Timmons Fellowship for Leukemia Research, and Swim Across America.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the latest thought leadership on your Blood Cancer delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.